Clinical trials
Completed Lymphoma, Large B-Cell, Diffuse trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
861 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 49 |
| 2001 | 20 |
| 2002 | 34 |
| 2003 | 38 |
| 2004 | 39 |
| 2005 | 39 |
| 2006 | 34 |
| 2007 | 47 |
| 2008 | 33 |
| 2009 | 30 |
| 2010 | 29 |
| 2011 | 36 |
| 2012 | 26 |
| 2013 | 28 |
| 2014 | 19 |
| 2015 | 23 |
| 2016 | 28 |
| 2017 | 34 |
| 2018 | 35 |
| 2019 | 20 |
| 2020 | 29 |
| 2021 | 23 |
| 2022 | 15 |
| 2023 | 7 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 861 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 83 |
| Fred Hutchinson Cancer Center | 52 |
| Memorial Sloan Kettering Cancer Center | 31 |
| Case Comprehensive Cancer Center | 22 |
| Mayo Clinic | 18 |
| M.D. Anderson Cancer Center | 16 |
| Novartis Pharmaceuticals | 16 |
| City of Hope Medical Center | 15 |
| Hoffmann-La Roche | 14 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 861 |
| Lymphoma, Follicular | 463 |
| Lymphoma, Non-Hodgkin | 447 |
| Lymphoma, Mantle-Cell | 434 |
| Lymphoma | 413 |
| Burkitt Lymphoma | 389 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 376 |
| Lymphoma, B-Cell, Marginal Zone | 361 |
| Lymphoma, Large-Cell, Immunoblastic | 356 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 344 |
Trials
Showing 51 to 75 of 861. Each trial links to its page on Pharma Observatory.
761 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.